Rare mutations are defined as mutations other than EGFR 19del and L858R and account for only 10% to 20% of all EGFR mutations.[1] The study of these rare mutations has progressed at a slow rate mainly because of tumor heterogeneity. The gene discussed is EGFR; the disease is neoplasm.